2018-12-01
LRP10 in α-synucleinopathies – Authors' reply
Publication
Publication
The Lancet Neurology , Volume 17 - Issue 12 p. 1035- 1036
We thank Kia and colleagues, Guerreiro
and colleagues, Pihlstrøm and colleagues,
Tesson and colleagues, and
Shi and colleagues for their interest in
our work.
Kia and colleagues, Guerreiro
and colleagues, and Pihlstrøm and
colleagues seek replication of our
findings by mining existing wholeexome
sequencing data from patients
with Parkinson’s disease, dementia
with Lewy bodies, or multiple system
atrophy and controls, mostly of
white ancestry. They conclude that
evidence for association of rare LRP10
variants with disease was not found.
We appreciate their efforts to replicate
our results, but we have a number of
concerns regarding these analyses.
Additional Metadata | |
---|---|
doi.org/10.1016/S1474-4422(18)30408-3, hdl.handle.net/1765/112224 | |
The Lancet Neurology | |
Organisation | Department of Clinical Genetics |
Quadri, M., Mandemakers, W., Kuipers, D., Breedveld, G., & Bonifati, V. (2018). LRP10 in α-synucleinopathies – Authors' reply. The Lancet Neurology, 17(12), 1035–1036. doi:10.1016/S1474-4422(18)30408-3 |